Uploaded on Jan 21, 2022
Tuberculosis (TB) has been declared as a health emergency due to emergence of resistant strains of M. tuberculosis, multidrug resistant (MDR), extensively drug-resistant (XDR) TB strains and totally drug-resistant tuberculosis (TDR-TB) reported recently in some parts of the world. Therefore, the current situation necessitates developing new antitubercular agents acting on novel targets for effectively controlling TB.
Paper TSC June 2021
Research paper of Dr. Trupti Chitre Title: Exploring Pyrimidine Pharmacophore as Thymidine Monophosphate Kinase Inhibitors for Antitubercular Activity: A Review Authors: Trupti Sameer Chitre*, Kalyani Dhirendra Asgaonkar , Shital Manoj Patil , Muthu Kumaradoss Kathiravan and Subhash Balkrishna Padhye Journal Details: Current Topics in Medicinal Chemistry, 2016, 16, 3211-3223 Publisher: Bentham Science Publishers Description: Tuberculosis (TB) has been declared as a health emergency due to emergence of resistant strains of M. tuberculosis, multidrug resistant (MDR), extensively drug resistant (XDR) TB strains and totally drug resistant tuberculosis (TDR-TB) reported recently in some parts of the world. Therefore, the current situation necessitates developing new antitubercular agents acting on novel targets for effectively controlling TB. Thymidine Monophosphate Kinase (TMPKmt) enzyme is one such target, which is being explored. This review focuses on Structure Activity Relationship studies (SARs) and computational studies of various nucleotide and nucleoside derivatives of pyrimidine analogs reported as TMPKmt inhibitors. Photographs :
Comments